YIH
KLRS

Y-Intercept (HK)’s Kalaris Therapeutics, Inc. Common Stock KLRS Stock Holding History

Y-Intercept (HK)’s Portfolio KLRS Stock Details KLRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-8,455
Closed -$141K – 1898
2024
Q2 		$141K Buy
+8,455
New +$141K 0.01% 1218